WHO advises against non-sugar sweeteners for weight loss
Trying to lose weight? Don't rely on non-sugar sweeteners, the World Health Organization advises in newly released guidance.
Watch CBS News
Trying to lose weight? Don't rely on non-sugar sweeteners, the World Health Organization advises in newly released guidance.
When 51-year-old Amanda Jameson lost consciousness and nearly slipped into a diabetic coma, her cat Willow sprung into action; biting Amanda's partner who had fallen asleep watching TV, then leading him upstairs to her. "I can't thank her enough," Jameson said. "She is the world to me."
Pharmaceutical giant Eli Lilly is requesting fast-track approval from the Food and Drug Administration for its Type 2 diabetes medication tirzepatide to be sold as a weight loss drug. The company said that new studies have shown promising results. Nikki Battiste has more.
FDA approval for use of tirzepatide for chronic weight management could come this year, drugmaker Eli Lilly said.
Pharmaceutical giant Eli Lilly announced that it will cut insulin prices by up to 70% and cap out-of-pocket costs at $35. Lilia Luciano has the details.
Drugmaker Eli Lilly announced Wednesday it will reduce prices for some of its most commonly prescribed insulin products by up by to 70%, and expand a monthly $35 cap on prescription costs for insured patients. CBS News correspondent Lilia Luciano reported on the government's role in the process.
A small group of patient activists managed to turn U.S. insulin prices into a kitchen table issue in part through their use of Twitter.
A new FDA-approved drug delays the onset of type 1 diabetes and the need for insulin injections for several years. Dr. Jon LaPook shows how it works and the potentially life-changing impact.
Doctors say these drugs are highly effective for weight loss — and now, there's a shortage.
Dramatic stories about weight loss using popular drugs are trending on social media. People who need the drugs for other health issues now face shortages.
Health experts are pushing diabetes prevention during Hispanic Heritage Month. As CBS News' Debra Alfarone reports, health care providers are helping one Hispanic community in Maryland lower their risk to the disease.
The prices for the life-saving medication have made it inaccessible for some people with diabetes.